Abstract:
Background
Methods
Results
Conclusions
Keywords
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Biological PsychiatryReferences and Notes
- FDA approves new nasal spray medication for treatment-resistant depression.available only at a certified doctor’s office or clinic. 2019;
- Esketamine for Treatment-Resistant Depression - First FDA-Approved Antidepressant in a New Class.The New England journal of medicine. 2019; 381: 1-4
- Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression.Biol Psychiatry. 2010; 67: 139-145
- Principles of laboratory assessment of drug abuse liability and implications for clinical development.Drug Alcohol Depend. 2009; 105: S14-25
- Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability.Molecular psychiatry. 2021; 26: 6704-6722
- R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects.Transl Psychiatry. 2015; 5e632
- Comparison of antidepressant and side effects in mice after intranasal administration of (R,S)-ketamine, (R)-ketamine, and (S)-ketamine.Pharmacol Biochem Behav. 2019; 181: 53-59
- Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms.Pharmacological reviews. 2018; 70: 621-660
- Ketamine: NMDA Receptors and Beyond.The Journal of neuroscience : the official journal of the Society for Neuroscience. 2016; 36: 11158-11164
- Potentiation of mu-opioid receptor-mediated signaling by ketamine.Journal of neurochemistry. 2011; 119: 294-302
- Role of kappa-opioid receptors in the effects of salvinorin A and ketamine on attention in rats.Psychopharmacology (Berl). 2010; 210: 263-274
- A novel phencyclidine analog interacts selectively with mu opioid receptors.The Journal of pharmacology and experimental therapeutics. 1984; 230: 383-386
- Stereoselective interaction of ketamine with recombinant mu, kappa, and delta opioid receptors expressed in Chinese hamster ovary cells.Anesthesiology. 1999; 90: 174-182
- Prevention and Treatment of Opioid Misuse and Addiction: A Review.JAMA Psychiatry. 2019; 76: 208-216
- Kappa-opioid ligands in the study and treatment of mood disorders.Pharmacol Ther. 2009; 123: 334-343
- Randomized, double-blind, placebo-controlled trial of intravenous ketamine in acute asthma.Ann Emerg Med. 1996; 27: 170-175
- Deep-fUS: A Deep Learning Platform for Functional Ultrasound Imaging of the Brain Using Sparse Data.IEEE Trans Med Imaging. 2022; 41: 1813-1825
Paxinos G, Watson C (2005): The Rat Brain in Stereotaxic Coordinates. Compact 6th ed.
- O-(2-[18F]Fluoroethyl)-6-O-Desmethyl-Diprenorphine ([18F]FE-DPN) Preferentially Binds to Mu Opioid Receptors In Vivo.Molecular Imaging and Biology. 2022; : 6
- Enhancing ketamine translational pharmacology via receptor occupancy normalization.Neuropharmacology. 2014; 86: 174-180
Evans CJ, Cahill CM (2016): Neurobiology of opioid dependence in creating addiction vulnerability. F1000Res. 5.
- Regulation of mu-opioid receptors: desensitization, phosphorylation, internalization, and tolerance.Pharmacological reviews. 2013; 65: 223-254
- Chronic heroin self-administration desensitizes mu opioid receptor-activated G-proteins in specific regions of rat brain.The Journal of neuroscience : the official journal of the Society for Neuroscience. 2000; 20: 4555-4562
- Mechanisms of mu opioid receptor/G-protein desensitization in brain by chronic heroin administration.Life Sci. 2005; 77: 1140-1154
- Mouse model of the OPRM1 (A118G) polymorphism: differential heroin self-administration behavior compared with wild-type mice.Neuropsychopharmacology. 2015; 40: 1091-1100
- Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction.British journal of pharmacology. 2008; 154: 384-396
- It's MORe exciting than mu: crosstalk between mu opioid receptors and glutamatergic transmission in the mesolimbic dopamine system.Front Pharmacol. 2014; 5: 116
- mu-Opioid receptors modulate NMDA receptor-mediated responses in nucleus accumbens neurons.J Neurosci. 1997; 17: 11-22
- Direct association of Mu-opioid and NMDA glutamate receptors supports their cross-regulation: molecular implications for opioid tolerance.Curr Drug Abuse Rev. 2012; 5: 199-226
- The abuse liability of ketamine: A scoping review of preclinical and clinical studies.Journal of psychiatric research. 2022; 151: 476-496
- Major depression and comorbid substance use disorders.Curr Opin Psychiatry. 2008; 21: 14-18
- Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions.Archives of general psychiatry. 2007; 64: 566-576
- Ketamine: promising path or false prophecy in the development of novel therapeutics for mood disorders?.Neuropsychopharmacology. 2015; 40: 259-267
- A word to the wise about ketamine.The American journal of psychiatry. 2014; 171: 262-264
- Mechanisms of Action of Ketamine and Esketamine.The American journal of psychiatry. 2021; 178: 1130
- A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders.JAMA psychiatry. 2017; 74: 399-405
- Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation.The American journal of psychiatry. 2021; 178: 383-399
- Ketamine psychotherapy for heroin addiction: immediate effects and two-year follow-up.J Subst Abuse Treat. 2002; 23: 273-283
- Single versus repeated sessions of ketamine-assisted psychotherapy for people with heroin dependence.J Psychoactive Drugs. 2007; 39: 13-19
- Ketamine for the treatment of addiction: Evidence and potential mechanisms.Neuropharmacology. 2018; 142: 72-82
- A review of the nonmedical use of ketamine: use, users and consequences.J Psychoactive Drugs. 2000; 32: 419-433
- MDMA ('ecstasy') and other 'club drugs'. The new epidemic.Pediatr Clin North Am. 2002; 49: 415-433
- A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression.Am J Psychiatry. 2016; 173: 816-826
Janssen Pharmaceuticals (2019): Spravato: Highlights of prescribing information.
- Reduction of dopamine D(2/3) receptor binding in the striatum after a single administration of esketamine, but not R-ketamine: a PET study in conscious monkeys.Eur Arch Psychiatry Clin Neurosci. 2017; 267: 173-176
- Dual action of ketamine confines addiction liability.Nature. 2022; 608: 368-373
- Separate vmPFC Ensembles Control Cocaine Self-Administration Versus Extinction in Rats.J Neurosci. 2019; 39: 7394-7407
- Role of projections from ventral medial prefrontal cortex to nucleus accumbens shell in context-induced reinstatement of heroin seeking.J Neurosci. 2012; 32: 4982-4991
- The opioid system in depression.Neurosci Biobehav Rev. 2022; 140104800
- Effects of Mu-Opiate Receptor Gene Polymorphism rs1799971 (A118G) on the Antidepressant and Dissociation Responses in Esketamine Nasal Spray Clinical Trials.Int J Neuropsychopharmacol. 2020; 23: 549-558
- Time will tell. Reply to "Comments to pharmacological and behavioral divergence of ketamine enantiomers by Jordi Bonaventura et al." by Chen et al. Molecular psychiatry. 2022;
- Analytical pharmacology: the impact of numbers on pharmacology.Trends Pharmacol Sci. 2011; 32: 189-196
- Sex Differences in the Behavioral, Molecular, and Structural Effects of Ketamine Treatment in Depression.Int J Neuropsychopharmacol. 2022; 25: 75-84
- Efficacy and safety of esketamine nasal spray by sex in patients with treatment-resistant depression: findings from short-term randomized, controlled trials.Arch Womens Ment Health. 2022; 25: 313-326
- Effect of chronic delivery of the Toll-like receptor 4 antagonist (+)-naltrexone on incubation of heroin craving.Biol Psychiatry. 2013; 73: 729-737
- Noninvasive quantification of dopamine D2 receptors with iodine-123-IBF SPECT.J Nucl Med. 1996; 37: 513-520
- Probabilistic TFCE: A generalized combination of cluster size and voxel intensity to increase statistical power.Neuroimage. 2019; 185: 12-26
- Neural correlates of blood flow measured by ultrasound.Neuron. 2022;
- Functional ultrasound imaging of the brain.Nature methods. 2011; 8: 662-664
- Real-Time High-Framerate In Vivo Cardiac SLSC Imaging with a GPU-Based Beamformer.Ieee Int Ultra Sym. 2015;
- Spatiotemporal Clutter Filtering of Ultrafast Ultrasound Data Highly Increases Doppler and fUltrasound Sensitivity.IEEE Trans Med Imaging. 2015; 34: 2271-2285
- Awake Rat Brain Functional Magnetic Resonance Imaging Using Standard Radio Frequency Coils and a 3D Printed Restraint Kit.Front Neurosci. 2018; 12: 548
- Whole-brain functional ultrasound imaging in awake head-fixed mice.Nat Protoc. 2021; 16: 3547-3571
Article info
Publication history
Publication stage
In Press Journal Pre-ProofFootnotes
One-Sentence Summary: (S)-ketamine binds and activates mu opioid receptors to induce desensitization and increased heroin self-administration in rats.